Catalyst Wire Dossier Catalyst Wire Dossier

Pediococcus acidilactici PA53

Pediococcus acidilactici PA53 · Wecare Probiotics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pediococcus acidilactici PA53, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults [NA]

See pricing